Protagonist Therapeutics, Inc.

PTGX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$113,713$168,543$139,653$97,249
Short-Term Investments$462,404$401,922$434,707$321,664
Receivables$583$27,971$27,088$168,490
Inventory$0$0$0$0
Other Curr. Assets$4,742$0$0$0
Total Curr. Assets$586,424$602,526$605,860$591,641
Property Plant & Equip (Net)$12,274$12,697$12,530$12,607
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$102,703$102,493$123,517$140,252
Tax Assets$0$0$0$0
Other NC Assets$287$290$225$225
Total NC Assets$115,264$115,480$136,272$153,084
Other Assets$0$0$0$0
Total Assets$701,688$718,006$742,132$744,725
Liabilities
Payables$5,646$3,249$2,917$1,615
Short-Term Debt$0$0$0$0
Tax Payable$0$0$1,889$2,689
Deferred Revenue$0$14,688$16,895$18,891
Other Curr. Liab.$14,390$5,006$2,899$23,693
Total Curr. Liab.$44,942$35,507$35,112$47,398
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$2,788$5,375$8,176$11,676
Total NC Liab.$11,309$14,481$17,968$22,032
Other Liabilities$0$0$0$0
Cap. Leases$10,749$11,279$11,360$10,866
Total Liabilities$56,251$49,988$53,080$69,430
Equity
Pref Stock$0$0$0$0
Common Stock$1$1$1$1
Retained Earnings-$426,287-$386,948-$352,177-$340,522
AOCI$525-$15$85-$82
Other Equity$0$0$0$0
Total Equity$645,437$668,018$689,052$675,295
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$701,688$718,006$742,132$744,725
Net Debt-$113,713-$168,543-$139,653-$97,249